PDE5 inhibitors

Results: 177



#Item
131June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU

June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-06-27 01:00:46
1321 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-30 17:40:11
133Print IYH Cosmetic_Label_Eng.qxd

Print IYH Cosmetic_Label_Eng.qxd

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-06-24 14:19:21
134HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS. Adempas (riociguat) tablets, for oral

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS. Adempas (riociguat) tablets, for oral

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-09 14:51:40
135•  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT.

• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-06-04 11:53:45
136DIVISION OF BIOEQUIVALENCE REVIEW

DIVISION OF BIOEQUIVALENCE REVIEW

Add to Reading List

Source URL: www.fda.gov

Language: English
137LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION

LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:45:49
138CIALIS®  1 ANL 5215 AMP  (tadalafil)

CIALIS® 1 ANL 5215 AMP (tadalafil)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:45:47
139Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology:

Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology:

Add to Reading List

Source URL: www.ncats.nih.gov

Language: English - Date: 2014-05-12 12:58:36
140Ohio Department of Agriculture and Ohio Department of Health Governor John R. Kasich

Ohio Department of Agriculture and Ohio Department of Health Governor John R. Kasich

Add to Reading List

Source URL: www.agri.ohio.gov

Language: English - Date: 2014-05-29 09:21:59